跳至主要内容
临床试验/NCT04740697
NCT04740697招募中不适用

Pilot Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Institut Claudius Regaud2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年2月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
2
主要终点
Rate of patients who adhere to tamoxifen treatment.

研究概览

简要总结

This is a pilot, prospective, interventional, monocentric study designed to evaluate, in a real-life situation, adherence to tamoxifen treatment as a function of the taking of alternative and complementary therapies in patients with localized hormone-dependent breast cancer.

200 patients will be included in the study.

Each patient will be followed for one day.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Months 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years at entry into the study.
  • Patient treated for hormone-dependent localized breast cancer requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
  • Patients treated with tamoxifen for a maximum of 1 to 3 years.
  • Patient affiliated with a Social Security system in France.
  • Patients who signed informed consent prior to inclusion in the study and prior to any specific study procedures.

排除标准

  • Pregnant or breastfeeding women.
  • Any psychological, family, geographical or sociological condition that does not allow the medical follow-up and/or the procedures foreseen in the study protocol to be respected.
  • Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

研究组 & 干预措施

Patient with localized breast cancer.

Other

干预措施: Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen. (Other)

结局指标

主要结局

Rate of patients who adhere to tamoxifen treatment.

时间窗: 18 months after the start of the research

This outcome will be assessed by the completion of the GIRERD questionnaire by the patient.

次要结局

  • Plasma concentration of tamoxifen in patients.(18 months after the start of the research)
  • Rate of patients taking ACT.(18 months after the start of the research)
  • Rate of patients consuming turmeric-based dietary supplements.(18 months after the start of the research)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Study to Evaluate the Impact of the Use of... | 临床试验